437 related articles for article (PubMed ID: 2946795)
1. Metabolic effects of a biphasic oral contraceptive preparation containing ethinyloestradiol and desogestrel on serum lipoproteins and apolipoproteins.
Voorhoof L; Rosseneu M; Caster H; De Keersgieter W
J Endocrinol; 1986 Oct; 111(1):191-6. PubMed ID: 2946795
[TBL] [Abstract][Full Text] [Related]
2. Effects of desogestrel and gestodene in low-dose oral contraceptive combinations on lipid and lipoprotein status. A randomized prospective study.
Granata A; Sobbrio GA; D'Arrigo F; Barillari M; Curasì MP; Egitto M; Trimarchi F; Granese D; Pullè C
Acta Eur Fertil; 1990; 21(3):143-6. PubMed ID: 2149913
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptive tablets containing 20 and 30 micrograms of ethinyl estradiol with 150 micrograms desogestrel. Their influence on lipids, lipoproteins, sex hormone binding globulin and testosterone.
Akerlund M; Almström E; Högstedt S; Nabrink M
Acta Obstet Gynecol Scand; 1994 Feb; 73(2):136-43. PubMed ID: 8116352
[TBL] [Abstract][Full Text] [Related]
4. A randomized crossover comparison of two low-dose contraceptives: effects on serum lipids and lipoproteins.
März W; Gross W; Gahn G; Romberg G; Taubert HD; Kuhl H
Am J Obstet Gynecol; 1985 Oct; 153(3):287-93. PubMed ID: 2931988
[TBL] [Abstract][Full Text] [Related]
5. A two-year clinical study of the effects of two triphasic oral contraceptives on plasma lipids.
Kakis G; Powell M; Marshall A; Woutersz TB; Steiner G
Int J Fertil Menopausal Stud; 1994; 39(5):283-91. PubMed ID: 7820162
[TBL] [Abstract][Full Text] [Related]
6. Fasting plasma lipids, lipoproteins and apolipoproteins in Nigerian women using combined oral and progestin-only injectable contraceptives.
Oyelola OO
Contraception; 1993 May; 47(5):445-54. PubMed ID: 8513671
[TBL] [Abstract][Full Text] [Related]
7. Contraceptives containing desogestrel or levonorgestrel have different effects on serum lipoproteins and post-heparin plasma lipase activities.
Kauppinen-Mäkelin R; Kuusi T; Ylikorkala O; Tikkanen MJ
Clin Endocrinol (Oxf); 1992 Feb; 36(2):203-9. PubMed ID: 1533186
[TBL] [Abstract][Full Text] [Related]
8. The clinical and biochemical effects of two combination oral contraceptive agents.
Sapire KE; Berger GM; Maritz JS
S Afr Med J; 1991 Apr; 79(7):376-9. PubMed ID: 1826569
[TBL] [Abstract][Full Text] [Related]
9. Association of cholesterol concentrations in low-density lipoprotein, high-density lipoprotein, and high-density lipoprotein subfractions, and of apolipoproteins AI and AII, with coronary stenosis and left ventricular function.
Kempen HJ; van Gent CM; Buytenhek R; Buis B
J Lab Clin Med; 1987 Jan; 109(1):19-26. PubMed ID: 3098880
[TBL] [Abstract][Full Text] [Related]
10. Metabolic profile of six oral contraceptives containing norgestimate, gestodene, and desogestrel.
Teichmann A
Int J Fertil Menopausal Stud; 1995; 40 Suppl 2():98-104. PubMed ID: 8574257
[TBL] [Abstract][Full Text] [Related]
11. The effects of two monophasic oral contraceptives containing 30 mcg of ethinyl estradiol and either 2 mg of chlormadinone acetate or 0.15 mg of desogestrel on lipid, hormone and metabolic parameters.
Winkler UH; Sudik R
Contraception; 2009 Jan; 79(1):15-23. PubMed ID: 19041436
[TBL] [Abstract][Full Text] [Related]
12. Comparison of the metabolic effects of two hormonal contraceptive methods: an oral formulation and a vaginal ring. II. Serum lipoproteins and apolipoproteins.
Ahrén T; Lithell H; Victor A; Vessby B; Johansson ED
Contraception; 1981 Oct; 24(4):451-68. PubMed ID: 6797786
[TBL] [Abstract][Full Text] [Related]
13. Comparative effects of monophasic desogestrel plus ethinyloestradiol and triphasic levonorgestrel plus ethinyloestradiol on lipid metabolism.
Kloosterboer HJ; van Wayjen RG; van den Ende A
Contraception; 1986 Aug; 34(2):135-44. PubMed ID: 2946552
[TBL] [Abstract][Full Text] [Related]
14. A randomized study on the influence of oral contraceptives containing ethinylestradiol combined with drospirenone or desogestrel on lipid and lipoprotein metabolism over a period of 13 cycles.
Gaspard U; Endrikat J; Desager JP; Buicu C; Gerlinger C; Heithecker R
Contraception; 2004 Apr; 69(4):271-8. PubMed ID: 15033400
[TBL] [Abstract][Full Text] [Related]
15. Effects of levonorgestrel and desogestrel in low-dose oral contraceptive combinations on serum lipids, apolipoproteins A-I and B and glycosylated proteins.
Bergink EW; Kloosterboer HJ; Lund L; Nummi S
Contraception; 1984 Jul; 30(1):61-72. PubMed ID: 6236951
[TBL] [Abstract][Full Text] [Related]
16. Lipid metabolic studies in women with a polycystic ovary syndrome during treatment with a low-dose desogestrel-ethinylestradiol combination.
Cullberg G; Hamberger L; Mattsson LA; Mobacken H; Samsioe G
Acta Obstet Gynecol Scand; 1985; 64(3):203-7. PubMed ID: 3160212
[TBL] [Abstract][Full Text] [Related]
17. Changes in lipoprotein composition in women receiving two low-dose oral contraceptives containing ethinylestradiol and gonane progestins.
Harvengt C; Desager JP; Gaspard U; Lepot M
Contraception; 1988 Jun; 37(6):565-75. PubMed ID: 2969320
[TBL] [Abstract][Full Text] [Related]
18. Serum lipids and proteins during treatment with a new oral contraceptive combination containing desogestrel.
Penttilä IM; Bergink EW; Holma P; Hulkko S; Makkonen M; Pyörälä T; Castrén O
Eur J Obstet Gynecol Reprod Biol; 1983 Dec; 16(4):275-81. PubMed ID: 6232161
[TBL] [Abstract][Full Text] [Related]
19. Metabolic effects of two low-dose triphasic oral contraceptives containing ethinyl estradiol and levonorgestrel or gestodene.
Lepot MR; Gaspard UJ
Int J Fertil; 1987; 32 Suppl():15-20. PubMed ID: 2906343
[TBL] [Abstract][Full Text] [Related]
20. Changes in the distribution and composition of high-density lipoproteins in primary hypothyroidism.
Muls E; Rosseneu M; Lamberigts G; De Moor P
Metabolism; 1985 Apr; 34(4):345-53. PubMed ID: 3920475
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
